MAY 01, 2017 6:53 PM PDT

Cytokine "Cocktail" Lowers Risk of Corneal Graft Rejection

WRITTEN BY: Kara Marker

Corneal transplants can be especially risky for some patients, when steroids intended to suppress the immune system fail to prevent graft rejection. A new approach alters the graft instead of the immune system to improve the chance of a successful procedure, and preclinical results show promise.

Source: Hoopes Vision

Like a window that needs to let light into a room so people can see, the cornea helps focus light into the eye to facilitate the sensation of sight. When the cornea is damaged due to scarring or disease, a corneal transplant is necessary. The procedure is vastly common, with more than 150,000 corneal transplants completed annually across the globe. Conditions that can cause the type of corneal damage leading up to a transplant procedure include infections like herpes keratitis, trauma or injury, and hereditary diseases like Fuchs’ dystrophy.

Steroid treatments inhibit the immune system’s natural response to foreign corneas, but the too-common failure of steroids to prevent graft rejection led experts to estimate that nearly one-third of all corneal transplants are considered to be at high risk of rejection. From the Massachusetts Eye and Ear Infirmary, a new approach involves applying a cocktail of cytokines, TGF-beta and IL-10, directly to donor corneal tissue to overcome the flaws encountered with only using steroid treatments.

Cytokines are chemical messenger cells that facilitate communication in a variety of ways in the immune system. For the purpose of the new approach for improving corneal transplants, this particular mix of cytokines targets antigen-presenting immune cells in donor tissues to make the foreign tissue tolerable by the host immune system after the procedure.

"We exposed donor tissue to a particular cocktail of immunoregulatory cytokines, and we've determined what doses, concentrations and exposure we need for these cytokines to generate tolerance inducing antigen-presenting cells in the cornea,” explained senior author Reza Dana, MD, MPH.

Dana’s new technique has already had some success in preclinical model results: 68.7 percent of grafts with new pretreatment cocktail survived after eight weeks as opposed to zero percent of the control grafts.

"By exposing the transplant tissue to these cytokines, we avoid having to expose the transplant recipients themselves to any immunosuppressive," Dana explained. "When we grafted the tissue that has been treated that way, we developed active tolerance, which leads to long-term acceptance of the corneal transplant and suppresses all the destructive sides of immunity."

Dana and his team are especially exciting about the potentially quick application of the new cytokine cocktail to clinical models for study. Failure rates for high-risk corneal transplants are usually 50 percent or greater, and lowering the rate of transplant failure could be lifechanging for people with severe corneal diseases causing pain and blindness.

The present study was published in the journal Scientific Reports.

Sources: American Academy of Ophthalmology, Massachusetts Eye and Ear Infirmary, International Anesthesiology Clinics, National Eye Institute

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUL 29, 2020
Immunology
Immune Variation Explains Different COVID-19 Outcomes
JUL 29, 2020
Immune Variation Explains Different COVID-19 Outcomes
Immune systems respond differently to coronavirus infection. People experience the disease causes by coronavirus, COVID- ...
OCT 12, 2020
Genetics & Genomics
The Malaria Parasite Can Change Host Cell Genetics
OCT 12, 2020
The Malaria Parasite Can Change Host Cell Genetics
Mosquitoes can transmit the malaria-causing Plasmodium parasite to humans. Malaria was estimated to have caused the deat ...
OCT 24, 2020
Immunology
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
OCT 24, 2020
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
A team of researchers at Duke University have developed an imaging technology for tagging structures at a cellular level ...
NOV 05, 2020
Immunology
Awakening Ancient DNA to Kill Cancer
NOV 05, 2020
Awakening Ancient DNA to Kill Cancer
In a recent study published in Nature, scientists from the University of Toronto described the discovery of ancient DNA ...
NOV 09, 2020
Drug Discovery & Development
COVID-19 Vaccine by Pfizer More than 90% Effective
NOV 09, 2020
COVID-19 Vaccine by Pfizer More than 90% Effective
A preliminary analysis of Pfizer and BioNTech's COVID-19 vaccine shows that it can prevent over 90% of people from c ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...